With the rise of COVID-19, Johns Hopkins neurosurgeon Chetan Bettegowda started looking at how cancer immunotherapies could play a role in the treatment of cytokine storms being seen in patients with COVID-19.
Johns Hopkins experts connect with colleagues around the world about their experiences with COVID-19. In this video, David Eisele, director of otolaryngology, and Carole Fakhry, chief of head and neck surgery, speak with Johns Hopkins ...
In this Q&A, Robert Stevens, associate director of the Neurocritical Care Precision Medicine Center of Excellence, shares insights on assessing patients presenting with COVID-19 and neurological symptoms.
Rehabilitation specialists are helping patients admitted to ICU with COVID-19 via routine psychological care and physical and occupational therapy.
Johns Hopkins Medicine’s experts discuss the latest in treating patients, protecting visitors and staff and up-to-date information to healthcare providers during the novel coronavirus (COVID-19) pandemic.